De Novo Biotherapeutics
Team & Investors
Leadership, board of directors, and investment partners
Executives
0
Board Members
0
Investors
5
Total Funding
$8.4M
Investors
5 investors across all rounds
AI
Atinum Investment
HS
Heungkuk Securities
IC
IBK Changgong
OTHER
KN
KDB NextRound
SV
Stonebridge Ventures (Seoul)
Explore More Data
Detailed analysis for De Novo Biotherapeutics
De Novo Biotherapeutics Leadership & Investors
De Novo Biotherapeutics is led by a team of experienced leaders. The company has attracted investment from 5 institutional and strategic investors.
Who Has Invested in De Novo Biotherapeutics?
De Novo Biotherapeutics has raised $8.4M from 5 investors including venture capital firms, private equity investors, and strategic partners.
Investment Opportunity
Accredited investors can access De Novo Biotherapeutics shares through secondary market platforms like Premier Alternatives, joining the company's existing institutional investor base.